Other News

Following an external audit, the NIHR Oxford Biomedical Research Centre (BRC) has again been successfully certified to the internationally recognised ISO 9001:2015 standard. Oxford is the only NIHR BRC in the country to have designated ISO 9001 certification. The audit of the BRC’s funding Management System was carried out by ACS Registrars Ltd, a UKAS-accredited … Read more

As part of Open Access Week, the Oxford BRC in collaboration with the Bodleian Libraries have organised a training event for researchers on what open access is. Open access (OA) research papers are digital, online, free of charge and free of most copyright and licensing restrictions. It is made possible by the internet and the … Read more

The risks associated with shoulder replacement surgery for arthritic conditions are higher than previously estimated, particularly for people under 60 and over 85 years old, according to a study supported by the NIHR Oxford BRC. The findings show that one in four men aged 55-59 years is at risk of needing further revision surgery, especially … Read more

The world’s first gene therapy trial for a genetic cause of blindness known as choroideremia has shown positive results. The trial, supported by NIHR Oxford Biomedical Research Centre (BRC), began in 2011 at the Oxford Eye Hospital, part of the Oxford University Hospitals NHS Foundation Trust. Reported on Monday 8 October in the Nature Medicine … Read more

A one-day event in Oxford today is offering a unique opportunity to for healthcare industry figures from the US and Europe to engage with two of the world’s leading universities to explore the many ways healthcare will be transformed. The Healthcare Technologies of the Future Conference is being jointly organised by the University of Oxford … Read more

The leading academic who has overseen the expansion of world-leading medical research at the NIHR Oxford Biomedical Research Centre (BRC) for the past nine years is stepping down. Professor Keith Channon will be replaced as Director of the Oxford BRC by Professor Helen McShane, a leading vaccine specialist. Prof Channon was appointed to lead the … Read more

A study supported by the NIHR Oxford Biomedical Research Centre has concluded that iron supplements on their own are not enough to efficiently tackle anaemia in places with high infection burdens. In a paper published in The BMJ, Prof Hal Drakesmith from the MRC Human Immunology Unit, based at Oxford’s John Radcliffe Hospital, and collaborators in Australia … Read more

The first ever drug specifically designed to prevent migraines in adults has been approved by the European Medicines Agency (EMA), and the head of the Oxford Headache Centre has said the news represents a new approach in treating the condition. The EMA granted a licence for the use of erenumab, manufactured by Novartis under the … Read more